Related Experiment Videos
Respiratory arrest during dipyridamole stress testing
G S Hillis1, A al-Mohammad, K P Jennings
1Department of Cardiology, Aberdeen Royal Hospitals NHS Trust, Foresterhill, UK.
Postgraduate Medical Journal
|May 1, 1997
Summary
Radionuclide scanning for myocardial perfusion is common, but dipyridamole can cause bronchospasm. This case highlights risks of dipyridamole or adenosine in emphysema patients, leading to respiratory arrest.
Area of Science:
- Cardiology
- Pulmonary Medicine
- Nuclear Medicine
Background:
- Radionuclide scanning is increasingly used to evaluate myocardial perfusion.
- Dipyridamole is the most common pharmacologic stress agent for this procedure.
- While generally safe, dipyridamole has been associated with acute bronchospasm in asthmatic patients.
Observation:
- A case of respiratory arrest occurred in a patient with emphysema during dipyridamole-induced stress testing.
- This represents a previously unreported severe adverse event associated with this diagnostic modality.
- The patient had underlying chronic lung disease, specifically emphysema.
Findings:
- Intravenous dipyridamole administration posed a significant risk in this patient with emphysema.
- Adenosine, another commonly used vasodilator, may also carry similar risks.
- The case underscores the potential for severe respiratory complications beyond bronchospasm.
Implications:
- Clinicians should exercise extreme caution when considering dipyridamole or adenosine for myocardial perfusion imaging in patients with chronic lung disease.
- Alternative stress agents or imaging techniques may be warranted for patients with emphysema.
- This case highlights the need for careful patient selection and risk assessment in pharmacologic stress testing.